Principal Scientist (Director) - Outcomes Research - Lung Cancers

Merck•North Wales, PA

1d•$190,800 - $300,300•Hybrid

About The Position

This position is within the Value and Implementation, Outcomes Research organization, which generates real-world evidence and outcomes research to support sustained patient access to company innovations and improve patient health outcomes. Under the guidance of a senior leader, the Principal Scientist is responsible for Outcomes Research strategy and value evidence activities supporting a Lung Cancers program. The role leads Outcomes Research strategy for a specific Lung Cancer program and contributes to value evidence activities for in-line and pipeline products. It provides outcomes research leadership to regional and global cross-functional teams and assesses reimbursement and market-access drivers and barriers. The position also designs and oversees non-interventional and data-synthesis studies, develops study materials and reports, manages study contracts, budgets, and vendors, and prepares payer and health technology assessment evidence dossiers. The role supports country affiliates in understanding local evidence needs and adapting health economic evaluations and outcomes research materials to local requirements. It communicates research and health economic modeling data to internal and external stakeholders, maintains awareness of scientific and methodological developments, builds relationships with scientific experts worldwide, and presents and publishes research findings.

Requirements

Advanced or professional degree in a relevant discipline, such as Outcomes Research, Health Economics, Epidemiology, Pharmaceutical Administration, Public Health, Health Policy, Medicine, or Clinical Pharmacy.
At least 4 years of experience after a doctoral degree or at least 7 years after a master's degree in the life sciences industry conducting non-interventional research and generating value evidence.
Oncology experience.
Skills in decision making, including gathering and interpreting quantitative and qualitative information, evaluating alternatives, and making timely decisions.
Emotional intelligence and ability to build trust, communicate in both directions, and work with difficult stakeholders while achieving business results.
Ability to build partnerships and leverage relationships within and across work groups.
Ability to create novel solutions with measurable value and experiment with new approaches to work problems.
Knowledge of the evolving payer and reimbursement environment.
Cancer epidemiology, cross-functional teamwork, observational studies, outcomes research, real-world data, real-world evidence (RWE), stakeholder relationship management, and strategic planning.

Nice To Haves

PhD in a relevant discipline, such as Outcomes Research, Health Economics, Epidemiology, Pharmaceutical Administration, Health Policy, or Public Health.
Lung cancer or thoracic malignancies experience.

Responsibilities

Lead Outcomes Research strategy for a specific Lung Cancer program and contribute to value evidence activities for in-line and pipeline products.
Obtain senior management approval of value evidence generation plans.
Provide outcomes research leadership on cross-functional regional and global teams.
Assess drivers and barriers to reimbursement and market access with internal teams, and contribute to clinical, payer/access, marketing, and value evidence generation strategies and programs.
Design non-interventional and data-synthesis studies with internal teams and external partners.
Author study protocols, measurement questionnaires, case report forms, data analysis plans, final study reports, scientific presentations, and publications.
Manage study-related contracting, budgets, and vendors or partners.
Develop American Managed Care Pharmacy dossiers for US payers and Global Value Dossiers.
Develop supplementary clinical data packages for Health Technology Assessment agency submissions in partnership with local country affiliates and the Health Technology Assessment statistics group.
Support country affiliates in identifying local evidence-generation needs and adapting health economic evaluations and outcomes research documents to local requirements.
Communicate outcomes research and health economic modeling data to internal teams and external stakeholders.
Maintain awareness of scientific and methodological developments within the therapeutic area.
Build relationships with scientific experts worldwide.
Present outcomes research data at national and international congresses and publish articles in scientific journals.
Educate asset teams on the impact of US Value Assessment and other key market HTA requirements, and possible mitigation strategies.